Delivery of opioids through an inhalation route
Details for Australian Patent Application No. 2002303833 (hide)
International Classifications
Event Publications
12 December 2002 Complete Application Filed
Priority application(s): 60/294,203 24.05.01 US; 60/317,479 05.09.01 US
8 May 2003 Application Open to Public Inspection
Published as AU-B-2002303833
15 December 2005 Assignment before Grant
Alexza Molecular Delivery Corporation The application has been assigned to Alexza Pharmaceuticals, Inc.
29 November 2007 Application Accepted
Published as AU-B-2002303833
3 April 2008 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002303834-DELIVERY OF COMPOUNDS FOR THE TREATMENT OF PARKINSONS THROUGH AN INHALATION ROUTE
2002303832-P.AERUGINOSA MUCOID EXOPOLYSACCHARIDE SPECIFIC BINDING PEPTIDES
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser